AB
ARCT icon

Amalgamated Bank’s Arcturus Therapeutics ARCT Stock Holding History

Amalgamated Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-795
Closed -$5K – 1699
2025
Q4 		$5K Sell
795
-14
-2% -$151 ﹤0.01% 2687
2025
Q3 		$15K Hold
809
– – ﹤0.01% 2254
2025
Q2 		$11K Hold
809
– – ﹤0.01% 2383
2025
Q1 		$9K Hold
809
– – ﹤0.01% 2396
2024
Q4 		$14K Hold
809
– – ﹤0.01% 2259
2024
Q3 		$19K Hold
809
– – ﹤0.01% 2143
2024
Q2 		$20K Hold
809
– – ﹤0.01% 2112
2024
Q1 		$27K Sell
809
-1,358
-63% -$48.1K ﹤0.01% 2023
2023
Q4 		$68K Sell
2,167
-241
-10% -$5.73K ﹤0.01% 2123
2023
Q3 		$62K Hold
2,408
– – ﹤0.01% 2158
2023
Q2 		$69K Sell
2,408
-755
-24% -$20.6K ﹤0.01% 2193
2023
Q1 		$76K Sell
3,163
-490
-13% -$8.79K ﹤0.01% 2143
2022
Q4 		$62K Hold
3,653
– – ﹤0.01% 2331
2022
Q3 		$54K Buy
3,653
+52
+1% +$873 ﹤0.01% 2418
2022
Q2 		$57K Buy
3,601
+1,059
+42% +$20.8K ﹤0.01% 2407
2022
Q1 		$69K Buy
+2,542
New +$64.9K ﹤0.01% 2321

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amalgamated Bank's ARCT Position: Q1 2026 in Review

Amalgamated Bank sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 795 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in ARCT in Q1 2022 and held it in 16 quarters. The position peaked at $76K in Q1 2023. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

  • Amalgamated Bank reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 795 Arcturus Therapeutics shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Arcturus Therapeutics in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Arcturus Therapeutics position peaked at $76K in Q1 2023.
  • 124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.